Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Serana, Federico ^a   Sottini, Alessandra ^a   Caimi, Luigi ^a   Palermo, Belinda ^b   Natali, Pier Giorgio ^b   Nisticò, Paola ^b   Imberti, Luisa ^a  

^a Spedali Civili di Brescia   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; HLA A2 ANTIGEN; LEUCINE; MELAN A; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR J BETA CHAIN; T LYMPHOCYTE RECEPTOR V BETA CHAIN; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; MART1 ANTIGEN; TUMOR ANTIGEN; TUMOR PROTEIN;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNIZATION; CELL CLONING; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; MELANOMA; PROTEIN MOTIF; SEQUENCE ANALYSIS; T LYMPHOCYTE; TUMOR IMMUNITY; CELL CLONE; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; HLA-A2 ANTIGEN; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 65249118742     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-21     Document Type: Article

References (65)

1. Lefranc MP Giudicelli V Ginestoux C Bodmer J Müller W Bontrop R Lemaitre M Malik A Barbié V Chaume D IMGT, the international ImMunoGeneTics database Nucleic Acids Res 1999, 27:209-212. 148137 9847182 10.1093/nar/27.1.209
2. Pannetier C Cochet M Darche S Casrouge A Zöller M Kourilsky P The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments Proc Natl Acad Sci USA 1993, 90:4319-4323. 46498 8483950 10.1073/ pnas.90.9.4319
3. Cabaniols JP Fazilleau N Casrouge A Kourilsky P Kanellopoulos JM Most alpha/beta T cell receptor diversity is due to terminal deoxynucleotidyl transferase J Exp Med 2001, 194:1385-1390. 2195970 11696602 10.1084/ jem.194.9.1385
4. Turner SJ Doherty PC McCluskey J Rossjohn J Structural determinants of T-cell receptor bias in immunity Nat Rev Immunol 2006, 6:883-894. 10.1038/nri1977 17110956
5. Dietrich PY Le Gal FA Dutoit V Pittet MJ Trautman L Zippelius A Cognet I Widmer V Walker PR Michielin O Guillaume P Connerotte T Jotereau F Coulie PG Romero P Cerottini JC Bonneville M Valmori D Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen J Immunol 2003, 170:5103-5109. 12734356
6. Trautmann L Labarrière N Jotereau F Karanikas V Gervois N Connerotte T Coulie P Bonneville M Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens Eur J Immunol 2002, 32:3181-3190. 10.1002/ 1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2 12555663
7. Vignard V Lemercier B Lim A Pandolfino MC Guilloux Y Khammari A Rabu C Echasserieau K Lang F Gougeon ML Dreno B Jotereau F Labarriere N Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells J Immunol 2005, 175:4797-4805. 16177129
8. Mantovani S Gabelli S Palermo B Campanelli R Brazzelli V Borroni G Martinetti M Benvenuto F Merlini G della Cuna GR Rivoltini L Giachino C Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patient J Invest Dermatol 2003, 121:308-314. 10.1046/j.1523-1747.2003.12368.x 12880423
9. Mantovani S Palermo B Gabelli S Campanelli R della Cuna GR Gennari R Benvenuto F Lantelme E Giachino C Dominant TCR-alpha requirements for a self antigen recognition in humans J Immunol 2002, 169:6253-6260. 12444131
10. Cole DJ Weil DP Shamamian P Rivoltini L Kawakami Y Topalian S Jennings C Eliyahu S Rosenberg SA Nishimura MI Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope Cancer Res 1994, 54:5265-5268. 7522957
11. Cole DJ Wilson MC Rivoltini L Custer M Nishimura MI T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes Cancer Res 1997, 57:5320-5327. 9393756
12. Dietrich PY Walker PR Quiquerez AL Perrin G Dutoit V Liénard D Guillaume P Cerottini JC Romero P Valmori D Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires Cancer Res 2001, 61:2047-2054. 11280765
13. Jäger E Höhn H Necker A Förster R Karbach J Freitag K Neukirch C Castelli C Salter RD Knuth A Maeurer MJ Peptide-specific CD8+ T-cell evolution in vivo: Response to peptide vaccination with Melan-A/ MART-1 Int J Cancer 2002, 98:376-388. 10.1002/ijc.10165 11920589
14. Mandruzzato S Rossi E Bernardi F Tosello V Macino B Basso G Chiarion-Sileni V Rossi CR Montesco C Zanovello P Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient J Immunol 2002, 169:4017-4024. 12244204
15. Romero P Gervois N Schneider J Escobar P Valmori D Pannetier C Steinle A Wolfel T Lienard D Brichard V van Pel A Jotereau F Cerottini JC Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma J Immunol 1997, 159:2366-2374. 9278327
16. Sensi M Traversari C Radrizzani M Salvi S Maccalli C Mortarini R Rivoltini L Farina C Nicolini G Wölfel T Brichard V Boon T Bordignon C Anichini A Parmiani G Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/ MART-1 Proc Natl Acad Sci USA 1995, 92:5674-5678. 41759 7777568 10.1073/ pnas.92.12.5674
17. Speiser DE Baumgaertner P Barbey C Rubio-Godoy V Moulin A Corthesy P Devevre E Dietrich PY Rimoldi D Liénard D Cerottini JC Romero P Rufer N A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: Spontaneous priming and efficient boosting by vaccination J Immunol 2006, 177:1338-1348. 16818795
18. Valmori D Dutoit V Schnuriger V Quiquerez AL Pittet MJ Guillaume P Rubio-Godoy V Walker PR Rimoldi D Liénard D Cerottini JC Romero P Dietrich PY Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity J Immunol 2002, 168:4231-4240. 11937585
19. Pittet MJ Gati A Le Gal FA Bioley G Guillaume P de Smedt M Plum J Speiser DE Cerottini JC Dietrich PY Romero P Zippelius A Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex J Immunol 2006, 176:2330-2336. 16455990
20. Palermo B Campanelli R Garbelli S Mantovani S della Cuna GR Necker A Manganoni AM Carella G Rivoltini L Lantelme E Giachino C Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: A qualitative analysis Melanoma Res 2002, 12:491-498. 10.1097/00008390-200209000-00011 12394191
21. Dutoit V Rubio-Godoy V Pittet MJ Zippelius A Dietrich PY Legal FA Guillaume P Romero P Cerottini JC Houghten RA Pinilla C Valmori D Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans J Exp Med 2002, 196:207-216. 2193921 12119345 10.1084/jem.20020242
22. Berger TG Haendle I Schrama D Lüftl M Bauer N Pedersen LØ Schuler Thurner B Hohenberger W Straten PtP Schuler G Becker JC Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells Int J Cancer 2004, 111:229-237. 10.1002/ijc.20238 15197776
23. Carsana M Tragni G Nicolini G Bersani I Parmiani G Anichini A Sun YS Möller P Schadendorf D Sensi ML Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine Cancer Gene Ther 2002, 9:243-253. 10.1038/ sj.cgt.7700435 11896440
24. Dufour E Carcelain G Gaudin C Flament C Avril MF Faure F Diversity of the cytotoxic melanoma-specific immune response: Some CTL clones recognize autologous fresh tumor cells and not tumor cell lines J Immunol 1997, 158:3787-3795. 9103444
25. Farina C Bruggen van der P Boël P Parmiani G Sensi M Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigens Int Immunol 1996, 8:1463-1466. 10.1093/intimm/8.9.1463 8921424
26. Ferradini L Mackensen A Genevée C Bosq J Duvillard P Avril MF Hercend T Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion J Clin Invest 1993, 91:1183-1190. 288075 8450047 10.1172/JCI116278
27. Mackensen A Ferradini L Carcelain G Triebel F Faure F Viel S Hercend T Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma Cancer Res 1993, 53:3569-3573. 8339262
28. Manne J Mastrangelo MJ Sato T Berd D TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine J Immunol 2002, 169:3407-3412. 12218163
29. McKee MD Clay TM Diamond RA Rosenberg SA Nishimura MI Quantitation of T-cell receptor frequencies by competitive polymerase chain reaction: dynamics of T-cell clonotype frequencies in an expanding tumor-infiltrating lymphocyte culture J Immunother 2000, 23:419-429. 10.1097/00002371-200007000-00005 10916751
30. Pisarra P Mortarini R Salvi S Anichini A Parmiani G Sensi M High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition Cancer Immunol Immunother 1999, 48:39-46. 10.1007/s002620050546 10235487
31. Protheroe AS Pickard C Johnson PW Craddock T Shefta J Short K Lancaster F Selby PJ Henwood J Boylston AW Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue Br J Haematol 2000, 111:766-773. 10.1046/ j.1365-2141.2000.02427.x 11122136
32. Puisieux I Even J Pannetier C Jotereau F Favrot M Kourilsky P Oligoclonality of tumor-infiltrating lymphocytes from human melanomas J Immunol 1994, 153:2807-2818. 8077684
33. Romero P Pannetier C Herman J Jongeneel CV Cerottini JC Coulie PG Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1 J Exp Med 1995, 182:1019-1028. 2192298 7561675 10.1084/jem.182.4.1019
34. Sensi M Salvi S Castelli C Maccalli C Mazzocchi A Mortarini R Nicolini G Herlyn M Parmiani G Anichini A T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone J Exp Med 1993, 178:1231-1246. 2191209 8376931 10.1084/ jem.178.4.1231
35. Sensi M Farina C Maccalli C Lupetti R Nicolini G Anichini A Parmiani G Berd D Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine J Clin Invest 1997, 99:710-717. 507854 9045874 10.1172/JCI119215
36. Shilyansky J Nishimura MI Yannelli JR Kawakami Y Jacknin LS Charmley P Rosenberg SA T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines Proc Natl Acad Sci USA 1994, 91:2829-2833. 43464 7511820 10.1073/pnas.91.7.2829
37. Strohal R Brna C Mossbacher U Fischer G Pehamberger H Stingl G First comparative delineation of the T cell receptor repertoire in primary and multiple subsequent/coexisting metastatic melanoma sites J Invest Dermatol 1998, 111:1085-1091. 10.1046/j.1523-1747.1998.00450.x 9856821
38. Thor Straten P Schøller J Hou-Jensen K Zeuthen J Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas Int J Cancer 1994, 56:78-86. 8262682
39. Willhauck M Scheibenbogen C Pawlita M Möhler T Thiel E Keilholz U Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy Cancer Res 2003, 63:3483-3485. 12839930
40. Zarour H De Smet C Lehmann F Marchand M Lethé B Romero P Boon T Renauld JC The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100 J Invest Dermatol 1996, 107:63-67. 10.1111/1523-1747.ep12298177 8752841
41. Zhou J Dudley ME Rosenberg SA Robbins PF Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma J Immunol 2004, 173:7622-7629. 2174603 15585890
42. Lehner PJ Wang EC Moss PA Williams S Platt K Friedman SM Bell JI Borysiewicz LK Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment J Exp Med 1995, 181:79-91. 2191841 7807026 10.1084/ jem.181.1.79
43. Lim A Trautmann L Peyrat MA Couedel C Davodeau F Romagné F Kourilsky P Bonneville M Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: Application to direct detection of their molecular imprint on the human peripheral T cell repertoire J Immunol 2000, 165:2001-2011. 10925283
44. Moss PA Moots RJ Rosenberg WM Rowland-Jones SJ Bodmer HC McMichael AJ Bell JI Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide Proc Natl Acad Sci USA 1991, 88:8987-8990. 52636 1833769 10.1073/ pnas.88.20.8987
45. Price DA Brenchley JM Ruff LE Betts MR Hill BJ Roederer M Koup RA Migueles SA Gostick E Wooldridge L Sewell AK Connors M Douek DC Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses J Exp Med 2005, 202:1349-1361. 2212993 16287711 10.1084/jem.20051357
46. Trautmann L Rimbert M Echasserieau K Saulquin X Neveu B Dechanet J Cerundolo V Bonneville M Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses J Immunol 2005, 175:6123-6132. 16237109
47. Wilson JD Ogg GS Allen RL Goulder PJ Kelleher A Sewell AK O'Callaghan CA Rowland-Jones SL Callan MF McMichael AJ Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific J Exp Med 1998, 188:785-790. 2213349 9705961 10.1084/jem.188.4.785
48. Echchakir H Vergnon I Dorothée G Grunenwald D Chouaib S Mami-Chouaib F Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung Int Immunol 2000, 12:537-546. 10.1093/intimm/ 12.4.537 10744655
49. Echchakir H Dorothée G Vergnon I Menez J Chouaib S Mami-Chouaib F Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution Proc Natl Acad Sci USA 2002, 99:9358-9363. 123145 12093915 10.1073/pnas.142308199
50. Heemskerk MH Hoogeboom M de Paus RA Kester MG Hoorn van der MA Goulmy E Willemze R Falkenburg JH Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region Blood 2003, 102:3530-3540. 10.1182/ blood-2003-05-1524 12869497
51. Höhn H Kortsik C Nilges K Necker A Freitag K Tully G Neukirch C Maeurer MJ Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+ T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion pattern Immunology 2001, 104:278-288. 1783313 11722642 10.1046/j.1365-2567.2001.01307.x
52. Ito M Shichijo S Tsuda N Ochi M Harashima N Saito N Itoh K Molecular basis of T cell-mediated recognition of pancreatic cancer cells Cancer Res 2001, 61:2038-2046. 11280764
53. Karanikas V Colau D Baurain JF Chiari R Thonnard J Gutierrez-Roelens I Goffinet C Van Schaftingen EV Weynants P Boon T Coulie PG High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival Cancer Res 2001, 61:3718-3724. 11325844
54. Niland B Banki K Biddison WE Perl A CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis J Immunol 2005, 175:8365-8378. 16339578
55. The International Immunogenetics Information System http://imgt.cines.fr/
56. Quiròs Roldan E Sottini A Bettinardi A Alberini A Imberti L Primi D Different TCRBV genes generate biased patterns of V-D-J diversity in human T cells Immunogenetics 1995, 41:91-100. 7806301
57. Candéias S Katz J Benoist C Mathis D Haskins K Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors Proc Natl Acad Sci USA 1991, 88:6167-6170. 52043 2068098 10.1073/pnas.88.14.6167
58. Nisticò P Capone I Palermo B Del Bello D Ferraresi V Moschella F Aricò E Valentini M Bracci L Cognetti F Ciccarese M Vercillo G Roselli M Fossile E Tosti ME Wang E Marincola F Imberti L Catricalà C Natali PG Belardelli F Proietti E Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients Int J Cancer 2009, 124:130-9. 10.1002/ijc.23886 18839429
59. Rudolph MG Wilson IA The specificity of TCR/pMHC interaction Curr Opin Immunol 2002, 14:52-65. 10.1016/S0952-7915(01)00298-9 11790533
60. Benicchi T Ghidini C Re A Cattaneo C Casari S Caimi L Rossi G Imberti L T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma Transplantation 2005, 80:673-682. 10.1097/01.tp.0000168490.29862.b8 16177644
61. Venturi V Price DA Douek DC Davenport MP The molecular basis for public T-cell responses? Nat Rev Immunol 2008, 8:231-238. 10.1038/nri2260 18301425
62. Cibotti R Cabaniols JP Pannetier C Delarbre C Vergnon I Kanellopoulos JM Kourilsky P Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice J Exp Med 1994, 180:861-872. 2191659 8064237 10.1084/ jem.180.3.861
63. Sliz P Michielin O Cerottini JC Luescher I Romero P Karplus M Wiley DC Crystal structures of two closely related but antigenically distinct HLA-A2/melanocyte-melanoma tumor-antigen peptide complexes J Immunol 2001, 167:3276-3284. 11544315
64. Yuan F Georgiou T Hillon T Gostick E Price DA Sewell AK Moysey R Gavarret J Vuidepot A Sami M Bell JI Gao GF Rizkallah PJ Jakobsen BK Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex Acta Crystallogr Sect F Struct Biol Cryst Commun 2007, 63:758-760. 10.1107/S1744309107037244 17768347
65. Thor Straten P Schrama D Andersen MH Becker JC T-cell clonotypes in cancer J Transl Med 2004 2 11 419379 15072580 10.1186/1479-5876-2-11